ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,980.87
-0.03%
US Tech 100
21,158.40
-0.02%
Dow Jones
42,171.66
-0.10%
Brent Oil
76.035
-1.93%
Bitcoin
104,277.59
-0.40%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sera Prognostics Inc (SERA) Quote

Sera Prognostics Inc

Sera Prognostics Inc (SERA)

NASDAQ
1.88
0.04
(2.17%)
Closed June 20 4:00PM
15 min delayed - Upgrade to Realtime
1.85
-0.03
(-1.60%)
After Hours: 7:50PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.85
Bid
1.85
Ask
1.97
Volume
266,101
1.805 Day's Range 1.92
1.37 52 Week Range 9.1297
Market Cap
69.695M
Previous Close
1.84
Open
1.84
Last Trade
53
@
1.86
Last Trade Time
Financial Volume
$ 495,120
VWAP
1.8606
Average Volume (3m)
209,628
Shares Outstanding
37,672,784
Dividend Yield
-
PE Ratio
-2.10
Earnings Per Share (EPS)
-0.89
Revenue
77k
Net Profit
-33.7M

About Sera Prognostics Inc

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.seraprognostics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Sera Prognostics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker SERA. The last closing price for Sera Prognostics was $1.84. Over the last year, Sera Prognostics shares have traded in a share price range of $ 1.37 to $ 9.1297.

Sera Prognostics currently has 37,672,784 shares outstanding. The market capitalization of Sera Prognostics is $69.32 million. Sera Prognostics has a price to earnings ratio (PE ratio) of -2.10.

Ask ADVFN Intelligence (AI)

SERA Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 12 2025
SERA (2.17%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 12 2025
SERA (2.17%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 12 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
SERA (2.17%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3523.33333333331.521.435592421.69526553CS
4-0.25-11.90476190482.12.281.373893421.67845501CS
12-2.21-54.43349753694.064.11.372096282.14266822CS
26-6.3508-77.44122524638.20089.12971.371665723.57064448CS
52-5.65-75.33333333337.59.12971.371522485.10301109CS
1560.5744.531251.2812.3551.13336654.50914381CS
260-13.16-87.674883411115.0115.51.12741954.68436411CS

SERA - Frequently Asked Questions (FAQ)

What is the current Sera Prognostics share price?
The current share price of Sera Prognostics is $ 1.85
How many Sera Prognostics shares are in issue?
Sera Prognostics has 37,672,784 shares in issue
What is the market cap of Sera Prognostics?
The market capitalisation of Sera Prognostics is USD 69.32M
What is the 1 year trading range for Sera Prognostics share price?
Sera Prognostics has traded in the range of $ 1.37 to $ 9.1297 during the past year
What is the PE ratio of Sera Prognostics?
The price to earnings ratio of Sera Prognostics is -2.1
What is the cash to sales ratio of Sera Prognostics?
The cash to sales ratio of Sera Prognostics is 940
What is the reporting currency for Sera Prognostics?
Sera Prognostics reports financial results in USD
What is the latest annual turnover for Sera Prognostics?
The latest annual turnover of Sera Prognostics is USD 77k
What is the latest annual profit for Sera Prognostics?
The latest annual profit of Sera Prognostics is USD -33.7M
What is the registered address of Sera Prognostics?
The registered address for Sera Prognostics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Sera Prognostics website address?
The website address for Sera Prognostics is www.seraprognostics.com
Which industry sector does Sera Prognostics operate in?
Sera Prognostics operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NWGLNature Wood Group Ltd
$ 5.615
(142.03%)
5.98M
KWEKWESST Micro Systems Inc
$ 11.2296
(94.96%)
37.36M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
APVOAptevo Therapeutics Inc
$ 5.01
(77.66%)
124.46M
MRINMarin Software Incorporated
$ 1.435
(68.82%)
50.06M
CBIOCrescent Biopharma Inc
$ 14.60
(-71.45%)
97.59k
CEROCERo Therapeutics Holdings Inc
$ 11.5501
(-41.75%)
3.03M
BMEABiomea Fusion Inc
$ 1.90
(-34.48%)
11.66M
PSTVPlus Therapeutics Inc
$ 0.2025
(-34.38%)
23.9M
CONIGraniteShares ETF Trust 2X Short COIN Daily ETF
$ 3.7198
(-32.49%)
21.46M
HCTIHealthcare Triangle Inc
$ 0.0265
(19.91%)
455.2M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
GNLNGreenlane Holdings Inc
$ 0.01035
(-0.48%)
260.94M
NVDANVIDIA Corporation
$ 145.48
(0.94%)
161.48M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.365
(3.56%)
141.16M

SERA Discussion

View Posts
glenn1919 glenn1919 1 week ago
SERA..........................................................https://stockcharts.com/h-sc/ui?s=SERA&p=D&yr=0&mn=2&dy=12&id=p84071410134
👍️0
glenn1919 glenn1919 2 weeks ago
SERA..................................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
SERA.................................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
SERA.............................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
SERA...............................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
👍️0
MiamiGent MiamiGent 2 years ago
Looking back, SERO had the best news this morning

$7.81 +5.71 (+271.91%)

BRIEF-Sera Prognostics Announces Primary Endpoint Criteria Met In Pivotal Prime Study Interim Look - Enrollment To Stop Due To Success
REUTERS 8:40 AM ET Dec-06-2023
Dec 6 (Reuters) - Sera Prognostics Inc (SERA.NaE):

* SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS Source text for Eikon: Further company coverage:
👍️0

Your Recent History

NASDAQ
SERA
Sera Prognostics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads